Suchergebnisse - "Pinato, David J"

PubPharm (285)

91

Clinical Utility of Albumin Bilirubin Grade as a Prognostic Marker in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: a Systematic Review and Meta-analysis

enthalten in: Journal of gastrointestinal cancer | 2022

von Mishra, G. | Majeed, A. | Dev, A. | +8

92

Clinical Utility of Albumin Bilirubin Grade as a Prognostic Marker in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: a Systematic Review and Meta-analysis

enthalten in: Journal of gastrointestinal cancer | 2022

von Mishra, G. | Majeed, A. | Dev, A. | +8

93

Clinical Utility of Albumin Bilirubin Grade as a Prognostic Marker in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: a Systematic Review and Meta-analysis

enthalten in: International journal of gastrointestinal cancer | 2022

von Mishra, G. | Majeed, A. | Dev, A. | +8

94

Safety and efficacy of percutaneous radiofrequency ablation for hepatocellular carcinoma : a textbook outcome analysis

enthalten in: HPB : the official journal of the International Hepato Pancreato Biliary Association | 2022

von Serra, C. | Cossiga, V. | Serenari, M. | +6

95

Response and Outcomes to Immune Checkpoint Inhibitors in Advanced Urothelial Cancer Based on Prior Intravesical Bacillus Calmette-Guerin

enthalten in: Clinical genitourinary cancer | 2022

von Talukder, R. | Makrakis, D. | Diamantopoulos, L. | +44

96

Immunotherapies for hepatocellular carcinoma

enthalten in: Nature reviews. Clinical oncology | 2022

von Llovet, J. | Castet, F. | Heikenwalder, M. | +6

97

Predictive biomarkers of response to immune checkpoint inhibitors in hepatocellular carcinoma

enthalten in: Expert review of molecular diagnostics | 2022

von Muhammed, A. | D'Alessio, A. | Enica, A. | +6

98

Host immune-inflammatory markers to unravel the heterogeneous outcome and assessment of patients with PD-L1 ≥50% metastatic non-small cell lung cancer and poor performance status receiving first-line immunotherapy

enthalten in: Thoracic cancer | 2022

von Banna, G. | Tiseo, M. | Cortinovis, D. | +31

99

Prognosis of patients with hepatocellular carcinoma treated with immunotherapy - development and validation of the CRAFITY score

enthalten in: Journal of hepatology | 2022

von Scheiner, B. | Pomej, K. | Kirstein, M. | +38

CommentIn: J Hepatol. 2022 Apr;76(4):987-988. - PMID 34780876

100

Prognostic effect of body mass index in patients with advanced NSCLC treated with chemoimmunotherapy combinations

enthalten in: Journal for immunotherapy of cancer | 2022

von Cortellini, A. | Ricciuti, B. | Vaz, V. | +32